| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | disaccharide binding | 7.10e-06 | 7 | 119 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 1.69e-05 | 9 | 119 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 2.18e-04 | 20 | 119 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | tubulin binding | 2.45e-04 | 428 | 119 | 10 | GO:0015631 | |
| GeneOntologyMolecularFunction | integrin binding involved in cell-matrix adhesion | 3.48e-04 | 5 | 119 | 2 | GO:0098640 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | CHRNA6 OR5M9 HTR2B FPR1 GPR84 GRID2 CHRNB3 OR10D3 LHCGR CELSR1 OR4C15 MS4A2 OR6C1 TLR3 OR4K5 TAS2R31 TAS2R43 TAS2R46 OR4K15 | 3.99e-04 | 1353 | 119 | 19 | GO:0004888 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 5.20e-04 | 6 | 119 | 2 | GO:1905030 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 5.44e-04 | 27 | 119 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 6.06e-04 | 28 | 119 | 3 | GO:0005251 | |
| GeneOntologyMolecularFunction | NAD-dependent protein lysine deacetylase activity | 7.25e-04 | 7 | 119 | 2 | GO:0034979 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5M9 HTR2B FPR1 GPR84 OR10D3 LHCGR CELSR1 OR4C15 OR6C1 OR4K5 TAS2R31 TAS2R43 TAS2R46 OR4K15 | 7.91e-04 | 884 | 119 | 14 | GO:0004930 |
| GeneOntologyMolecularFunction | taste receptor activity | 9.88e-04 | 33 | 119 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 1.23e-03 | 9 | 119 | 2 | GO:0098634 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 7.27e-07 | 4 | 118 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 2.29e-06 | 17 | 118 | 4 | GO:0043301 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 5.65e-06 | 21 | 118 | 4 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 1.00e-05 | 8 | 118 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 3.04e-05 | 63 | 118 | 5 | GO:0043300 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 3.23e-05 | 32 | 118 | 4 | GO:1903306 | |
| GeneOntologyBiologicalProcess | leukocyte degranulation | 3.67e-05 | 108 | 118 | 6 | GO:0043299 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | LGALS9C LGALS9B LRRK2 LGALS9 RASGRP1 MS4A2 PLEK CADPS2 FOXF1 | 4.57e-05 | 291 | 118 | 9 | GO:0045055 |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | RHBDD1 DPY19L2 LRRK2 ETV5 NR3C1 MAST2 NCAPH ADAM28 ADCY7 NME8 LGALS9 ACTL7A LHCGR SIRT2 BRCA2 CFAP221 PARN PRMT7 DPY19L2P2 | 4.64e-05 | 1194 | 118 | 19 | GO:0048609 |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 5.81e-05 | 37 | 118 | 4 | GO:0033081 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 6.46e-05 | 38 | 118 | 4 | GO:0001779 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 7.25e-05 | 309 | 118 | 9 | GO:0002703 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 7.90e-05 | 15 | 118 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 7.90e-05 | 15 | 118 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 9.63e-05 | 42 | 118 | 4 | GO:0043032 | |
| GeneOntologyBiologicalProcess | receptor clustering | 1.14e-04 | 83 | 118 | 5 | GO:0043113 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 1.17e-04 | 133 | 118 | 6 | GO:0032760 | |
| GeneOntologyBiologicalProcess | regulation of oxidoreductase activity | 1.21e-04 | 84 | 118 | 5 | GO:0051341 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 1.27e-04 | 45 | 118 | 4 | GO:0045920 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 1.38e-04 | 137 | 118 | 6 | GO:1903557 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 1.38e-04 | 46 | 118 | 4 | GO:0051353 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 1.40e-04 | 18 | 118 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | gamete generation | RHBDD1 DPY19L2 LRRK2 ETV5 MAST2 NCAPH ADAM28 NME8 ACTL7A LHCGR SIRT2 BRCA2 CFAP221 PARN PRMT7 DPY19L2P2 | 1.50e-04 | 982 | 118 | 16 | GO:0007276 |
| GeneOntologyBiologicalProcess | sexual reproduction | RHBDD1 DPY19L2 ADAM21 LRRK2 ETV5 MAST2 NCAPH PKDREJ ADAM28 NME8 ACTL7A LHCGR SIRT2 BRCA2 UBE3A CFAP221 PARN PRMT7 DPY19L2P2 | 1.61e-04 | 1312 | 118 | 19 | GO:0019953 |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 1.65e-04 | 19 | 118 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 1.65e-04 | 19 | 118 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 1.94e-04 | 20 | 118 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 2.27e-04 | 96 | 118 | 5 | GO:0002704 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5M9 PKDREJ WDR47 OR10D3 KCNA1 OR4C15 OR6C1 OR4K5 TAS2R31 TAS2R43 TAS2R46 OR4K15 FOXF1 | 2.52e-04 | 722 | 118 | 13 | GO:0051606 |
| GeneOntologyBiologicalProcess | regulation of CAMKK-AMPK signaling cascade | 3.21e-04 | 5 | 118 | 2 | GO:1905289 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5M9 HTR2B FPR1 LRRK2 GPR84 ADCY2 ADCY7 OR10D3 LHCGR CELSR1 OR4C15 MS4A2 OR6C1 OR4K5 TAS2R31 TAS2R43 PLEK TAS2R46 OR4K15 | 3.50e-04 | 1395 | 118 | 19 | GO:0007186 |
| GeneOntologyBiologicalProcess | regulation of regulated secretory pathway | 3.77e-04 | 165 | 118 | 6 | GO:1903305 | |
| GeneOntologyBiologicalProcess | regulation of exocytosis | 3.91e-04 | 233 | 118 | 7 | GO:0017157 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 4.13e-04 | 61 | 118 | 4 | GO:0032814 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 4.31e-04 | 26 | 118 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 4.67e-04 | 63 | 118 | 4 | GO:0007157 | |
| GeneOntologyBiologicalProcess | peptidyl-tryptophan modification | 4.80e-04 | 6 | 118 | 2 | GO:0018211 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via tryptophan | 4.80e-04 | 6 | 118 | 2 | GO:0018317 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan | 4.80e-04 | 6 | 118 | 2 | GO:0018406 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation | 4.80e-04 | 6 | 118 | 2 | GO:0018103 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 5.13e-04 | 320 | 118 | 8 | GO:0002274 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5M9 WDR47 OR10D3 KCNA1 OR4C15 OR6C1 OR4K5 TAS2R31 TAS2R43 TAS2R46 OR4K15 | 5.15e-04 | 582 | 118 | 11 | GO:0050906 |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 5.39e-04 | 28 | 118 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 5.97e-04 | 180 | 118 | 6 | GO:0060078 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | RHBDD1 DPY19L2 ADAM21 LRRK2 ETV5 MAST2 ADAM28 NME8 ACTL7A LHCGR SIRT2 BRCA2 UBE3A CFAP221 TLR3 PRMT7 DPY19L2P2 | 6.57e-04 | 1235 | 118 | 17 | GO:0003006 |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 6.62e-04 | 30 | 118 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | negative regulation of mast cell degranulation | 6.69e-04 | 7 | 118 | 2 | GO:0043305 | |
| GeneOntologyBiologicalProcess | detection of virus | 6.69e-04 | 7 | 118 | 2 | GO:0009597 | |
| GeneOntologyBiologicalProcess | regulation of secretion | LGALS9C CHRNA6 RHBDD1 LGALS9B LRRK2 NR3C1 KMO LGALS9 KCNA2 MS4A2 KCNC3 CADPS2 FOXF1 | 6.74e-04 | 801 | 118 | 13 | GO:0051046 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 7.30e-04 | 31 | 118 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 7.30e-04 | 31 | 118 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | mast cell degranulation | 8.60e-04 | 74 | 118 | 4 | GO:0043303 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 8.79e-04 | 33 | 118 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | corpus callosum development | 8.79e-04 | 33 | 118 | 3 | GO:0022038 | |
| GeneOntologyBiologicalProcess | exocytosis | LGALS9C LGALS9B LRRK2 LGALS9 RASGRP1 MS4A2 PLEK CADPS2 FOXF1 | 8.82e-04 | 434 | 118 | 9 | GO:0006887 |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | RHBDD1 DPY19L2 ETV5 MAST2 ACTL7A SIRT2 BRCA2 CFAP221 PRMT7 DPY19L2P2 | 9.02e-04 | 527 | 118 | 10 | GO:0022412 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 9.51e-04 | 76 | 118 | 4 | GO:0042269 | |
| GeneOntologyBiologicalProcess | mast cell mediated immunity | 9.51e-04 | 76 | 118 | 4 | GO:0002448 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 9.60e-04 | 34 | 118 | 3 | GO:0007190 | |
| GeneOntologyBiologicalProcess | mast cell activation involved in immune response | 1.05e-03 | 78 | 118 | 4 | GO:0002279 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | LGALS9C CHRNA6 LGALS9B LRRK2 NR3C1 KMO LGALS9 KCNA2 MS4A2 KCNC3 CADPS2 FOXF1 | 1.10e-03 | 740 | 118 | 12 | GO:1903530 |
| GeneOntologyBiologicalProcess | spermatogenesis | RHBDD1 DPY19L2 LRRK2 ETV5 MAST2 ADAM28 NME8 ACTL7A LHCGR BRCA2 CFAP221 DPY19L2P2 | 1.15e-03 | 744 | 118 | 12 | GO:0007283 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.15e-03 | 80 | 118 | 4 | GO:0002715 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | LRRK2 LGALS9 RASGRP1 SIRT2 MS4A2 BRCA2 ABCE1 CADPS2 NLRP4 FOXF1 | 1.18e-03 | 546 | 118 | 10 | GO:0051656 |
| GeneOntologyCellularComponent | juxtaparanode region of axon | 3.91e-05 | 12 | 120 | 3 | GO:0044224 | |
| GeneOntologyCellularComponent | motile cilium | TTLL9 NME8 ACTL7A GSTM3 CFAP221 DNAI2 TAS2R31 TAS2R43 TAS2R46 | 2.12e-04 | 355 | 120 | 9 | GO:0031514 |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.87e-04 | 25 | 120 | 3 | GO:0005858 | |
| HumanPheno | Abnormal fingertip morphology | 3.26e-05 | 203 | 33 | 8 | HP:0001211 | |
| HumanPheno | Clubbing | 4.08e-05 | 152 | 33 | 7 | HP:0001217 | |
| HumanPheno | Decreased fertility | MAGEL2 DPY19L2 NR3C1 NME8 ACTL7A GSTM3 LHCGR BRCA2 CFAP221 DNAI2 | 9.24e-05 | 380 | 33 | 10 | HP:0000144 |
| HumanPheno | Decreased fertility in males | 9.55e-05 | 236 | 33 | 8 | HP:0012041 | |
| HumanPheno | Bronchiectasis | 1.00e-04 | 175 | 33 | 7 | HP:0002110 | |
| HumanPheno | Infertility | 1.18e-04 | 314 | 33 | 9 | HP:0000789 | |
| Domain | BTB/POZ_dom | LZTR1 KBTBD8 MYNN KCNRG KLHL38 BTBD16 ZBTB39 KCNA1 KCNA2 KCNC3 | 2.54e-07 | 185 | 117 | 10 | IPR000210 |
| Domain | SKP1/BTB/POZ | LZTR1 KBTBD8 MYNN KCNRG KLHL38 BTBD16 ZBTB39 KCNA1 KCNA2 KCNC3 | 3.10e-07 | 189 | 117 | 10 | IPR011333 |
| Domain | BTB | 1.98e-06 | 180 | 117 | 9 | SM00225 | |
| Domain | BTB | 6.69e-05 | 160 | 117 | 7 | PS50097 | |
| Domain | Galectin_CRD | 1.03e-04 | 15 | 117 | 3 | IPR001079 | |
| Domain | Gal-bind_lectin | 1.03e-04 | 15 | 117 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 1.03e-04 | 15 | 117 | 3 | SM00908 | |
| Domain | GALECTIN | 1.03e-04 | 15 | 117 | 3 | PS51304 | |
| Domain | GLECT | 1.03e-04 | 15 | 117 | 3 | SM00276 | |
| Domain | ETS_PEA3_N | 1.16e-04 | 3 | 117 | 2 | IPR006715 | |
| Domain | ETS_PEA3_N | 1.16e-04 | 3 | 117 | 2 | PF04621 | |
| Domain | BTB | 1.76e-04 | 131 | 117 | 6 | PF00651 | |
| Domain | DUF1908 | 2.32e-04 | 4 | 117 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 2.32e-04 | 4 | 117 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 2.32e-04 | 4 | 117 | 2 | IPR023142 | |
| Domain | - | 2.32e-04 | 4 | 117 | 2 | 1.20.1480.20 | |
| Domain | Apc4_WD40_dom | 2.53e-04 | 20 | 117 | 3 | IPR024977 | |
| Domain | ANAPC4_WD40 | 2.53e-04 | 20 | 117 | 3 | PF12894 | |
| Domain | - | 3.27e-04 | 95 | 117 | 5 | 2.60.120.200 | |
| Domain | BTB_2 | 3.38e-04 | 53 | 117 | 4 | PF02214 | |
| Domain | T1-type_BTB | 3.38e-04 | 53 | 117 | 4 | IPR003131 | |
| Domain | THIOREDOXIN_1 | 4.98e-04 | 25 | 117 | 3 | PS00194 | |
| Domain | TAS2R | 5.61e-04 | 26 | 117 | 3 | PF05296 | |
| Domain | T2R | 5.61e-04 | 26 | 117 | 3 | IPR007960 | |
| Domain | WD40_repeat_dom | 5.67e-04 | 297 | 117 | 8 | IPR017986 | |
| Domain | Adcy_conserved_dom | 5.74e-04 | 6 | 117 | 2 | IPR009398 | |
| Domain | HELP | 5.74e-04 | 6 | 117 | 2 | PF03451 | |
| Domain | DUF1053 | 5.74e-04 | 6 | 117 | 2 | PF06327 | |
| Domain | HELP | 5.74e-04 | 6 | 117 | 2 | IPR005108 | |
| Domain | K_chnl_volt-dep_Kv | 6.28e-04 | 27 | 117 | 3 | IPR003968 | |
| Domain | SIR2 | 8.00e-04 | 7 | 117 | 2 | PF02146 | |
| Domain | Ssirtuin_cat_dom | 8.00e-04 | 7 | 117 | 2 | IPR026590 | |
| Domain | Sirtuin | 8.00e-04 | 7 | 117 | 2 | IPR003000 | |
| Domain | SIRTUIN | 8.00e-04 | 7 | 117 | 2 | PS50305 | |
| Domain | Thioredoxin | 9.48e-04 | 31 | 117 | 3 | PF00085 | |
| Domain | AC_N | 1.06e-03 | 8 | 117 | 2 | IPR032628 | |
| Domain | Adcy | 1.06e-03 | 8 | 117 | 2 | IPR030672 | |
| Domain | K_chnl_volt-dep_Kv1 | 1.06e-03 | 8 | 117 | 2 | IPR003972 | |
| Domain | AC_N | 1.06e-03 | 8 | 117 | 2 | PF16214 | |
| Domain | VG_K_chnl | 1.14e-03 | 33 | 117 | 3 | IPR028325 | |
| Domain | - | 1.19e-03 | 333 | 117 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.24e-03 | 335 | 117 | 8 | IPR015943 | |
| Domain | WD40 | 1.50e-03 | 268 | 117 | 7 | SM00320 | |
| Domain | WD40_repeat | 1.63e-03 | 272 | 117 | 7 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.85e-03 | 278 | 117 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.89e-03 | 279 | 117 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.89e-03 | 279 | 117 | 7 | PS50294 | |
| Domain | - | 2.06e-03 | 11 | 117 | 2 | 3.40.50.1220 | |
| Domain | Thioredoxin_domain | 2.15e-03 | 41 | 117 | 3 | IPR013766 | |
| Domain | THIOREDOXIN_2 | 2.46e-03 | 43 | 117 | 3 | PS51352 | |
| Domain | DHS-like_NAD/FAD-binding_dom | 2.46e-03 | 12 | 117 | 2 | IPR029035 | |
| Domain | - | 3.38e-03 | 48 | 117 | 3 | 2.120.10.80 | |
| Domain | Myosin_N | 3.87e-03 | 15 | 117 | 2 | PF02736 | |
| Domain | Myosin_N | 3.87e-03 | 15 | 117 | 2 | IPR004009 | |
| Domain | Nicotinic_acetylcholine_rcpt | 4.41e-03 | 16 | 117 | 2 | IPR002394 | |
| Domain | Disintegrin_CS | 4.41e-03 | 16 | 117 | 2 | IPR018358 | |
| Domain | LRR_6 | 4.96e-03 | 55 | 117 | 3 | PF13516 | |
| Domain | Kelch-typ_b-propeller | 4.96e-03 | 55 | 117 | 3 | IPR015915 | |
| Domain | A/G_cyclase_CS | 4.98e-03 | 17 | 117 | 2 | IPR018297 | |
| Domain | Thioredoxin_CS | 4.98e-03 | 17 | 117 | 2 | IPR017937 | |
| Domain | Channel_four-helix_dom | 5.48e-03 | 57 | 117 | 3 | IPR027359 | |
| Domain | - | 5.48e-03 | 57 | 117 | 3 | 1.20.120.350 | |
| Domain | Myosin_tail_1 | 5.58e-03 | 18 | 117 | 2 | PF01576 | |
| Domain | Myosin_tail | 5.58e-03 | 18 | 117 | 2 | IPR002928 | |
| Domain | ADAM_CR | 5.58e-03 | 18 | 117 | 2 | PF08516 | |
| Domain | - | 5.58e-03 | 18 | 117 | 2 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 5.58e-03 | 18 | 117 | 2 | IPR029787 | |
| Domain | Kelch | 5.75e-03 | 58 | 117 | 3 | SM00612 | |
| Domain | WD40 | 5.83e-03 | 259 | 117 | 6 | PF00400 | |
| Domain | Guanylate_cyc | 6.21e-03 | 19 | 117 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 6.21e-03 | 19 | 117 | 2 | PS50125 | |
| Domain | A/G_cyclase | 6.21e-03 | 19 | 117 | 2 | IPR001054 | |
| Domain | Myosin-like_IQ_dom | 6.21e-03 | 19 | 117 | 2 | IPR027401 | |
| Domain | - | 6.21e-03 | 19 | 117 | 2 | 4.10.270.10 | |
| Domain | GUANYLATE_CYCLASE_1 | 6.21e-03 | 19 | 117 | 2 | PS00452 | |
| Domain | CYCc | 6.21e-03 | 19 | 117 | 2 | SM00044 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 19776007 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 33316546 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 9038233 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 28704475 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 4.21e-08 | 3 | 122 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 4.21e-08 | 3 | 122 | 3 | 22341088 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 32380082 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 23667648 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 28877989 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 19800850 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 38987795 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 37105392 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 36479526 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 4.21e-08 | 3 | 122 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 4.21e-08 | 3 | 122 | 3 | 33923930 | |
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 4.21e-08 | 3 | 122 | 3 | 31969388 | |
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 4.21e-08 | 3 | 122 | 3 | 35241678 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 22627368 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 33153471 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 22052881 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 4.21e-08 | 3 | 122 | 3 | 23408620 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 4.21e-08 | 3 | 122 | 3 | 29458010 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 26582205 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 9153289 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 18974023 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 4.21e-08 | 3 | 122 | 3 | 29651447 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 21146220 | ||
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 4.21e-08 | 3 | 122 | 3 | 28990062 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 18579572 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 16990264 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 18005988 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 23585851 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 4.21e-08 | 3 | 122 | 3 | 29433546 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 4.21e-08 | 3 | 122 | 3 | 25898318 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 31937306 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 21426359 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 18282810 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 24083426 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 4.21e-08 | 3 | 122 | 3 | 25931247 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 17560833 | ||
| Pubmed | 6.98e-08 | 12 | 122 | 4 | 23817958 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 38686388 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 22677125 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 19234217 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 35715604 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 19017954 | ||
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 1.68e-07 | 4 | 122 | 3 | 36459823 | |
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 1.68e-07 | 4 | 122 | 3 | 29611821 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 1.68e-07 | 4 | 122 | 3 | 33727589 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 25578313 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 18826117 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 38853593 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 1.68e-07 | 4 | 122 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 1.68e-07 | 4 | 122 | 3 | 18346632 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 19670381 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 1.68e-07 | 4 | 122 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 1.68e-07 | 4 | 122 | 3 | 34369876 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 33203936 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 1.68e-07 | 4 | 122 | 3 | 33963043 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 33107565 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 30763585 | ||
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 1.68e-07 | 4 | 122 | 3 | 19362679 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 29844236 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 1.68e-07 | 4 | 122 | 3 | 20463811 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 1.68e-07 | 4 | 122 | 3 | 23657851 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 24333756 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 1.68e-07 | 4 | 122 | 3 | 24958847 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 30120235 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 11839756 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 1.68e-07 | 4 | 122 | 3 | 22021615 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 28951537 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 4.19e-07 | 5 | 122 | 3 | 34847625 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 25158758 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 26278059 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 21385853 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 29242193 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 22469568 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 4.19e-07 | 5 | 122 | 3 | 19782405 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 4.19e-07 | 5 | 122 | 3 | 9566950 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 37352334 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 33664349 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 4.19e-07 | 5 | 122 | 3 | 37884694 | |
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 28394331 | ||
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 8.36e-07 | 6 | 122 | 3 | 20937702 | |
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 8674632 | ||
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 23296703 | ||
| Pubmed | Role of galectin-1 in the developing mouse olfactory system. | 1.46e-06 | 7 | 122 | 3 | 8873770 | |
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 23751344 | ||
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 31661141 | ||
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 36883358 | ||
| Pubmed | 3.48e-06 | 9 | 122 | 3 | 9488722 | ||
| Pubmed | 3.48e-06 | 9 | 122 | 3 | 21670307 | ||
| Cytoband | 12p13.2 | 2.39e-04 | 45 | 122 | 3 | 12p13.2 | |
| GeneFamily | Galectins | 5.92e-05 | 15 | 94 | 3 | 629 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 7.07e-05 | 134 | 94 | 6 | 861 | |
| GeneFamily | Sirtuins | 5.52e-04 | 7 | 94 | 2 | 938 | |
| GeneFamily | Taste 2 receptors | 1.09e-03 | 39 | 94 | 3 | 1162 | |
| GeneFamily | Potassium voltage-gated channels | 1.17e-03 | 40 | 94 | 3 | 274 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.17e-03 | 10 | 94 | 2 | 53 | |
| GeneFamily | WD repeat domain containing | 2.46e-03 | 262 | 94 | 6 | 362 | |
| GeneFamily | Myosin heavy chains | 2.69e-03 | 15 | 94 | 2 | 1098 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 3.06e-03 | 16 | 94 | 2 | 173 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 3.46e-03 | 17 | 94 | 2 | 1197 | |
| GeneFamily | NLR family | 7.42e-03 | 25 | 94 | 2 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 7.42e-03 | 25 | 94 | 2 | 994 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.63e-03 | 27 | 94 | 2 | 47 | |
| GeneFamily | ETS transcription factor family | 9.26e-03 | 28 | 94 | 2 | 534 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-07 | 184 | 121 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 9.67e-07 | 192 | 121 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 200 | 121 | 7 | f0e7c2f07a7065511bf0b6521ce2e74e04e48544 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 6.91e-06 | 169 | 121 | 6 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.59e-06 | 179 | 121 | 6 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 9.90e-06 | 180 | 121 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 184 | 121 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 185 | 121 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 186 | 121 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-05 | 186 | 121 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 186 | 121 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.23e-05 | 187 | 121 | 6 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 188 | 121 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 190 | 121 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-05 | 191 | 121 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.43e-05 | 192 | 121 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.43e-05 | 192 | 121 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.43e-05 | 192 | 121 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-05 | 192 | 121 | 6 | 4037b4c4fbb40541b8c424c36d3871a57891b8dd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-05 | 192 | 121 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.47e-05 | 193 | 121 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-05 | 194 | 121 | 6 | 705fa653c11b6c8a427e007533aa4a4bb5845078 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-05 | 194 | 121 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 343B-Myeloid-Dendritic|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-05 | 196 | 121 | 6 | fdb4f7e757b30b974ed3cd80c47beb4557a70845 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-05 | 196 | 121 | 6 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.65e-05 | 197 | 121 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | 61bda9b5102fdbce902bb976d1aa62f2c799d2fb | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.65e-05 | 197 | 121 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.65e-05 | 197 | 121 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.70e-05 | 198 | 121 | 6 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.70e-05 | 198 | 121 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.70e-05 | 198 | 121 | 6 | cc808d872d2404a79ec119bb0be62688a30c93a7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.70e-05 | 198 | 121 | 6 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 199 | 121 | 6 | e245851a5bddf56f7e13a7fb7c5fda2fd275dae3 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-05 | 145 | 121 | 5 | 778655fffd73df101e656154a41b478a1b695116 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-05 | 154 | 121 | 5 | cd99428c282d566b5dbd31fd5a0371b7ffe9ffa2 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 158 | 121 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 158 | 121 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-05 | 163 | 121 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-05 | 163 | 121 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Plasma_cells-IgM_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.81e-05 | 165 | 121 | 5 | 6e8370b8e747d8ef44a2413a993291a3cd83a77c | |
| ToppCell | CV-Mild-6|CV / Virus stimulation, Condition and Cluster | 9.32e-05 | 167 | 121 | 5 | cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-05 | 169 | 121 | 5 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.01e-04 | 170 | 121 | 5 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 171 | 121 | 5 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 171 | 121 | 5 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-04 | 172 | 121 | 5 | 53dbfe1ac658fd94370cf8e745048cb67fda1daf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-04 | 172 | 121 | 5 | fe3d0d8cb5f613ac2cfff450599698f1533a354f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | 15af4a0f7516dbf5c93ba66a19aca073ebe30d04 | |
| ToppCell | Epithelial-Epithelial-C_(AT2)|Epithelial / shred on cell class and cell subclass (v4) | 1.10e-04 | 173 | 121 | 5 | f57cbf5bd2a9e5db47b4919e9cd5e50781c1a990 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 176 | 121 | 5 | 98176bf3c961d5262593e2d5d002836adb010e13 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 176 | 121 | 5 | 4bba41ebf9dd187c8705a6997ed039878de62b4e | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 177 | 121 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 177 | 121 | 5 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 178 | 121 | 5 | dbde3305e0c6a81593fe614e3f2e746b32cc16a7 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.26e-04 | 178 | 121 | 5 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 1.29e-04 | 179 | 121 | 5 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 180 | 121 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 180 | 121 | 5 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 181 | 121 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 181 | 121 | 5 | bad77767e64cc093a827a6b0f3f401f3f108e457 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.36e-04 | 181 | 121 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 182 | 121 | 5 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 182 | 121 | 5 | c1e0be27064e14043b78ae501b02d4e9542267a3 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 182 | 121 | 5 | 3c9b4869d357884ae4bcd22a9872faf83a5cfc6d | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 121 | 5 | 876b4f128c2168fdae7488201ff44f19c06c8415 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 121 | 5 | b190b650e61b1b20baf5e42d04acac82d3fd1400 | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 1.43e-04 | 183 | 121 | 5 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 183 | 121 | 5 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 183 | 121 | 5 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 121 | 5 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-04 | 184 | 121 | 5 | 24cbe9f2461ea920954e44bf3b2c2a6a5d4debfb | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-04 | 184 | 121 | 5 | 98079fd048a63b51bbdf3833b6f15bf0ae99ea90 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.47e-04 | 184 | 121 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 184 | 121 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 184 | 121 | 5 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-04 | 184 | 121 | 5 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-04 | 184 | 121 | 5 | 86c1551c4f7c7d0c35c14852b01b1e602fa5092a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-04 | 185 | 121 | 5 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.51e-04 | 185 | 121 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-04 | 185 | 121 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 1.51e-04 | 185 | 121 | 5 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 185 | 121 | 5 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 185 | 121 | 5 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | proximal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.54e-04 | 186 | 121 | 5 | c920dffd24f051b54d8b48f801fffc928d99e135 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.54e-04 | 186 | 121 | 5 | d740aca5dc4240851ba7bc5988c0970d785ad0c2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-04 | 186 | 121 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 186 | 121 | 5 | cb4ea1bc1427230070e9696baeda7de241c354b1 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.54e-04 | 186 | 121 | 5 | 4ca7f6c043874a0c536f75af5ca24c7c66725e54 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 187 | 121 | 5 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | lymphoid-B_cell-Naive_B_cell|World / Lineage, cell class and subclass | 1.58e-04 | 187 | 121 | 5 | 904ffd8cf4513e86fcd4c2b7faf24a34fbd2dce3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 187 | 121 | 5 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-04 | 187 | 121 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 187 | 121 | 5 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 187 | 121 | 5 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | lymphoid-B_cell|World / Lineage, cell class and subclass | 1.58e-04 | 187 | 121 | 5 | 2abbc01fd7f5b4e52113699625287893c991f8da | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.62e-04 | 188 | 121 | 5 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 188 | 121 | 5 | 0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6 | |
| Disease | Lung Diseases, Obstructive | 4.35e-05 | 3 | 113 | 2 | C0600260 | |
| Disease | bipolar disorder (implicated_via_orthology) | 3.01e-04 | 7 | 113 | 2 | DOID:3312 (implicated_via_orthology) | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 4.01e-04 | 8 | 113 | 2 | DOID:14320 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 4.95e-04 | 169 | 113 | 5 | DOID:3908 (is_marker_for) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease, chronic bronchitis | 6.41e-04 | 10 | 113 | 2 | EFO_0000341, EFO_0006505 | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | cocaine use | 7.82e-04 | 11 | 113 | 2 | C3496069 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 8.34e-04 | 48 | 113 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | Malignant neoplasm of breast | KBTBD8 KIF16B ITGA9 PKDREJ NME8 TXN LHCGR NLRP9 BRCA2 FARP1 UQCC1 DHX32 | 8.59e-04 | 1074 | 113 | 12 | C0006142 |
| Disease | distal myopathy (implicated_via_orthology) | 9.36e-04 | 12 | 113 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 9.36e-04 | 12 | 113 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 9.36e-04 | 12 | 113 | 2 | C1861063 | |
| Disease | depressive disorder (biomarker_via_orthology) | 1.05e-03 | 52 | 113 | 3 | DOID:1596 (biomarker_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.10e-03 | 13 | 113 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | interleukin 12 measurement | 1.11e-03 | 53 | 113 | 3 | EFO_0004753 | |
| Disease | Hamman-Rich syndrome | 1.28e-03 | 14 | 113 | 2 | C0085786 | |
| Disease | sulfate measurement | 1.28e-03 | 14 | 113 | 2 | EFO_0007864 | |
| Disease | autoimmune thyroid disease | 1.43e-03 | 126 | 113 | 4 | EFO_0006812 | |
| Disease | obesity (implicated_via_orthology) | 1.45e-03 | 215 | 113 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.48e-03 | 15 | 113 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.68e-03 | 16 | 113 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | TTLL9 UBE3B KBTBD8 TXNDC11 CHRNB3 CAPN11 TK1 ASB3 DHX32 PLEK POLK TUBD1 MAST3 | 1.96e-03 | 1347 | 113 | 13 | EFO_0005192 |
| Disease | Stuttering | 2.26e-03 | 143 | 113 | 4 | HP_0025268 | |
| Disease | Usual Interstitial Pneumonia | 2.38e-03 | 19 | 113 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 2.38e-03 | 19 | 113 | 2 | C4721508 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 2.38e-03 | 19 | 113 | 2 | OBA_2045199 | |
| Disease | Bipolar Disorder | 2.45e-03 | 477 | 113 | 7 | C0005586 | |
| Disease | Prostatic Neoplasms | 2.59e-03 | 616 | 113 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.59e-03 | 616 | 113 | 8 | C0376358 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 2.64e-03 | 20 | 113 | 2 | C4721952 | |
| Disease | Idiopathic Pulmonary Fibrosis | 2.91e-03 | 21 | 113 | 2 | C1800706 | |
| Disease | asthma (is_implicated_in) | 3.17e-03 | 157 | 113 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 3.19e-03 | 22 | 113 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | Bronchiectasis | 3.19e-03 | 22 | 113 | 2 | C0006267 | |
| Disease | QRS duration, response to sulfonylurea | 3.49e-03 | 23 | 113 | 2 | EFO_0005055, EFO_0007922 | |
| Disease | Depression, Bipolar | 3.50e-03 | 79 | 113 | 3 | C0005587 | |
| Disease | non-melanoma skin carcinoma | 3.59e-03 | 265 | 113 | 5 | EFO_0009260 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.63e-03 | 80 | 113 | 3 | DOID:12930 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDCTTPLEMFSNVEF | 96 | Q96QE3 | |
| TSDPTFSLMFDGCFE | 1336 | Q96QE3 | |
| FSLMFDGCFEEIKFS | 1341 | Q96QE3 | |
| KFFETKCFMASFSTE | 166 | Q01362 | |
| DVTFFPFDRQNCSMK | 156 | Q05901 | |
| TCVLTKERFGDFMLF | 206 | P41595 | |
| ETVMTFFKSFPENCC | 296 | Q32M84 | |
| CVMDKALSFYIPTDF | 361 | Q9UKQ2 | |
| PAEKFTNCSYADFMK | 371 | Q9UKJ8 | |
| EKIAASFPFSFCVMD | 496 | O95267 | |
| SFPFSFCVMDKDREG | 501 | O95267 | |
| GFPDCSIEAAMVKVF | 371 | Q9H845 | |
| MKCVSVLRFDSSAPF | 1316 | Q9NYQ6 | |
| DCVCVMFASVPDFKV | 876 | P51828 | |
| MFASVPDFKVFYTEC | 881 | P51828 | |
| DFDSFISCFLRLKTM | 696 | Q9UMQ6 | |
| FCLYTEEFASKDMTP | 401 | Q7L7V1 | |
| DFMFEQCDPTLSLKV | 436 | Q9GZS0 | |
| QLMLESPDDIFCFKF | 391 | Q8IWG1 | |
| CTSVSPLQFDFKVMF | 516 | Q6DHV5 | |
| DKLAPAFTMSSCSFL | 946 | Q96MI9 | |
| FTQAKFDSEMPCETV | 231 | Q96L93 | |
| KFLEVMGFSCAAFTL | 191 | Q96RD1 | |
| PSFAEKCLDFLVDMF | 406 | Q96HW7 | |
| ADLSEFKEMTTCVFP | 306 | O95453 | |
| MAPTCVFLASKVEEF | 86 | P24863 | |
| VFSGSDTDPDMAFCK | 481 | O60568 | |
| KMPAFSSCFEVVSGA | 71 | Q5VV17 | |
| SFLDACFSSVITPKM | 66 | Q8NGM1 | |
| FFACPSKAGFFTNIM | 241 | P16389 | |
| FACPSKTDFFKNIMN | 241 | Q09470 | |
| CMAPISFFAISAAFK | 581 | P22888 | |
| FPVAVCRDKMFVFSG | 231 | Q8N653 | |
| PDIFSKASECMQVIF | 151 | P43361 | |
| SKDRMIFAATFCAPK | 746 | Q9UJ55 | |
| GMPFDLCFLVQSSDF | 96 | Q6DKI2 | |
| AGMTDFPKIFCETSQ | 86 | Q8N6Q8 | |
| GMPFDLCFLVQSSDF | 96 | Q3B8N2 | |
| GMPFDLCFLVQSSDF | 96 | O00182 | |
| RAEKTVDMFACLAPF | 551 | O43424 | |
| EECMFPKASDASFRA | 581 | A7E2Y1 | |
| NTSCDFLPAMKSAEF | 141 | Q96B96 | |
| ICQASFATPKMIADF | 71 | Q8NGD3 | |
| VCVASFATPKMIADF | 71 | Q8NH41 | |
| VYKFVCDPEALFSMA | 411 | P50549 | |
| SLFQAMVDFTFFKPD | 491 | Q9H7Z3 | |
| CKIKMEDFAFIANPS | 111 | Q9NPC7 | |
| ACPKVESFSARMNFL | 1151 | Q5S007 | |
| CFQTFLDKTMSIEFP | 736 | P04150 | |
| EFPNLKAFMCRFEAL | 181 | P21266 | |
| KFVCDPDALFSMAFP | 446 | P41161 | |
| FEMAKVLCKFSLFTA | 61 | Q9P2T1 | |
| AFFRVFGSCSKTIEM | 121 | Q8N5I3 | |
| FCCFFKDPKRAMEAF | 311 | Q96MN2 | |
| TCAPEFDFMEKATPL | 476 | Q6NUT2 | |
| CQMFPESASDAIKFV | 506 | P78316 | |
| PDFMVTLKTDFSARC | 896 | O94988 | |
| FFPDIVEFCEAMANA | 101 | P04183 | |
| SSEFGKVTRMCFAVF | 311 | Q9NQS5 | |
| FAKCIRFPLMEDTFI | 236 | Q8NFY9 | |
| SDFLKCSVGFPFMRS | 701 | Q13797 | |
| MFTFLFGEFESPACE | 206 | P0CF75 | |
| KPSFFQDCLMEVFDD | 106 | Q9NWS6 | |
| PAIFKSSCPMDITFF | 151 | Q15825 | |
| CIQKADIFMFDEPSS | 231 | P61221 | |
| VCVMFASIPDFKEFY | 886 | Q08462 | |
| FSSPVCMAFQKDCEF | 316 | Q9Y575 | |
| KSFTCTLFMPFEEFE | 231 | O15229 | |
| LAAMECAFPKEFANR | 2631 | P51587 | |
| GADFCYAIEVFKPMA | 86 | Q9NVM4 | |
| TLEFLMASRDFCKSF | 291 | Q9Y4F1 | |
| DSIMKFSECYGPVFT | 56 | P20853 | |
| CMFFNAVKEGDTVIF | 556 | Q86UW7 | |
| FAENPFVVSMFCSFD | 566 | Q6P0Q8 | |
| FAENPFVVSMFCSFE | 421 | O60307 | |
| TGDDFGMVKLFDFPC | 1906 | Q05BV3 | |
| CKDIPSFVIQMDFSA | 1811 | Q6ZMW3 | |
| TEFCAVYGFMPAKAT | 286 | Q9BY44 | |
| AAEDMKLFDASPTFF | 121 | Q9Y5Q0 | |
| DTLKYTCSPEFDFME | 281 | Q6ZN68 | |
| TCSPEFDFMEKATLL | 286 | Q6ZN68 | |
| TDFEFKLEALMCTNP | 536 | Q96EK7 | |
| ETFMFPCQHCERKFT | 356 | Q13029 | |
| LSVFDMGFSSVTCPK | 66 | Q8NH80 | |
| KSCDSFNSFMLPIDV | 741 | Q4G0U5 | |
| PSMCDRKEFVFSFNA | 336 | Q12946 | |
| FCLFKMGANVFDTDV | 131 | Q8IZC4 | |
| SFGSLENKPVFMFCK | 251 | P59538 | |
| SFGSLENKPVFMFCK | 251 | P59537 | |
| SFESLENKPVFMFCE | 251 | P59540 | |
| ENKPVFMFCEAIAFS | 256 | P59540 | |
| YLCKSEEFMDPATFI | 216 | Q8TBZ9 | |
| VAEFMDEPDFKRSCA | 126 | Q8TEB9 | |
| SMDFCFPLDFVSNLF | 21 | Q9H0A3 | |
| TDDKTFQCEMCFRFF | 821 | P57071 | |
| GPISTMFCDFTNDLF | 901 | Q9NTG1 | |
| TSPCQDFGKRMFVFK | 56 | P08567 | |
| DFCFTSTLPFFMVRK | 71 | P21462 | |
| ARFFSCMQSDFLKVD | 241 | Q8IXJ6 | |
| FADVCFSSNVTPKML | 66 | Q8NGP3 | |
| AFETTLGKMVPSFCS | 821 | Q4LDE5 | |
| FLCSEMFFKPSLIKS | 316 | Q9Y615 | |
| FESVLCAPDALFMVA | 81 | Q9UJS0 | |
| CAPDALFMVAFQLFD | 86 | Q9UJS0 | |
| IDPMFQKTAASFDEC | 241 | Q15003 | |
| KDRFTFVFFLNVCEM | 176 | Q7RTR0 | |
| ASECEVKCMPTFQFF | 66 | P10599 | |
| EVEKCDSFSGFFIIM | 126 | Q9UJT1 | |
| LPSSVFSCAFEQKML | 251 | O94967 | |
| PMKTDIFDEFFSSSA | 1056 | Q5W0Q7 | |
| CKDSAPFELFFMINT | 696 | O15455 | |
| TENKFSFMTCPFILN | 471 | Q05086 | |
| TCLQFNPKFMTFASA | 286 | Q6UXN9 | |
| EDAANVAKFMDAFFP | 291 | Q8N427 | |
| AMCSGAFFIPDQDTF | 136 | Q86VE9 | |
| CLDGPSISENFKMFS | 646 | Q9UBT6 | |
| LEEECMFPKATDTSF | 536 | Q9UKX3 | |
| EKTDFEEFFLRCQMP | 126 | Q9NVA1 | |
| GIFLFSCDMCETKFF | 396 | O15060 | |
| SVPQCSFFEMAAALD | 486 | Q6PKC3 | |
| EAPSSECMFSDFLTK | 51 | Q96TA2 | |
| PDERAMFLKFVTSCS | 966 | Q7Z3V4 | |
| LEAAKCDFFPKTFEM | 131 | Q3SXZ7 | |
| VPKEMFTVGCCVFAF | 491 | Q9H1V8 | |
| PSSSMADFRKFFAKA | 36 | Q9NXA8 | |
| KAAESMVKFYTCFPV | 951 | Q14966 | |
| TCEMFQDPVAFKDVA | 11 | Q8NDP4 | |
| FEFLMRITFCPDKVE | 361 | Q14003 | |
| ASMLQFPKLFEACSS | 111 | Q2WGJ6 |